NCT02066103View on ClinicalTrials.gov

Broncho-Adventitial Delivery of Paclitaxel to Extend Airway Patency in Malignant Airway Obstruction Patients

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Malignant Airway Obstruction Secondary to Non-small Cell Lung Cancer
Interventions
DRUG

Paclitaxel

Trial Locations (3)

21287

Johns Hopkins University, Baltimore

27599

The University of North Carolina at Chapel Hill, Chapel Hill

Unknown

Duke University, Raleigh

Sponsors
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Mercator MedSystems, Inc.

INDUSTRY

NCT02066103 - Broncho-Adventitial Delivery of Paclitaxel to Extend Airway Patency in Malignant Airway Obstruction Patients | Biotech Hunter | Biotech Hunter